StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Gilead Sciences (GILD) PT Lowered to $90 at RBC Capital
May 2, 2018 8:26 AM
RBC Capital lowered its price ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Gilead Sciences (GILD) PT Lowered to $79 at Baird
May 2, 2018 7:51 AM
Gilead Sciences (GILD) PT Lowered to $81 at Morgan Stanley
May 2, 2018 7:45 AM
Gilead Sciences (GILD) PT Lowered to $89 at Maxim Group
May 2, 2018 7:42 AM
Too many cancer drugs? Crowded market gives investors pause
May 2, 2018 7:14 AM
Gilead Sciences (GILD) PT Lowered to $85 at Cowen
May 2, 2018 6:31 AM
Gilead Sciences (GILD) PT Lowered to $72 at Leerink Partners
May 2, 2018 6:23 AM
Gilead (GILD) volatility elevated into less than expected Q1 results
May 2, 2018 3:54 AM
Gilead Sciences (GILD) PT Lowered to $90 at Barclays
May 2, 2018 3:54 AM
Gilead Sciences (GILD) Declares $0.57 Quarterly Dividend; 3.2% Yield
May 1, 2018 4:02 PM
Gilead Sciences (GILD) Misses Q1 EPS by 19c, Reiterates FY Guidance
May 1, 2018 4:02 PM
Gilead Sciences Announces Second Quarter 2018 Dividend
May 1, 2018 4:02 PM
Gilead Sciences Announces First Quarter 2018 Financial Results
May 1, 2018 4:01 PM
